Biblio Discovery — Demo Discovery Service

8 results for "Lin, L I"

Showing 1–8 · 0.52 seconds · RSS

  1. Journal Article Full text

    The spectrum of beta-thalassemia mutations in Taiwan: identification of a novel frameshift mutation.

    Lin, L I; Lin, K S; Lin, K H et al.

    Am J Hum Genet · 1991 · English · PubMed Central

    Seventy-four beta-thalassemia genes from 37 unrelated beta-thalassemia-major patients were systematically characterized by using PCR, dot-blot hybridization, and direct sequencing of amplified genomic DNA. We found that six mutations--namely, II-654, 41/42, -28, 17 beta, -29, and 27/28--were…

  2. Journal Article Full text

    Cell type-specific protein-DNA interactions in the human zeta-globin upstream promoter region: displacement of Sp1 by the erythroid cell-specific factor NF-E1.

    Yu, C Y; Chen, J; Lin, L I et al.

    Mol Cell Biol · 1990 · English · PubMed Central

    The protein-DNA interactions of the upstream promoter region of the human embryonic zeta-globin gene in nuclear extracts of erythroid K562 cells and nonerythroid HeLa cells were analyzed by DNase I footprinting, gel mobility shift assay, methylation interference, and oligonucleotide competition…

  3. Journal Article Full text

    Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia

    Lee, C-Y; Tien, H-F; Hu, C-Y et al.

    Br J Cancer · 2007 · English · PubMed Central

    Bone marrow (BM) neoangiogenesis plays an important role in acute myelogenous leukaemia (AML), and depends on the interplay of members of the vascular endothelial growth factor (VEGF) and angiopoietin (Ang) families. We determined the marrow levels of seven molecules associated with angiogenesis in…

  4. Journal Article Full text

    Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish

    Lu, J-W; Hsieh, M-S; Hou, H-A et al.

    Blood Cancer J · 2017 · English · PubMed Central

    The SOX4 transcription factor is a key regulator of embryonic development, cell-fate decision, cellular differentiation and oncogenesis. Abnormal expression of SOX4 is related to malignant tumor transformation and cancer metastasis. However, no reports are available regarding the clinical…

  5. Journal Article Full text

    Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia

    Hou, H-A; Lu, J-W; Lin, T-Y et al.

    Blood Cancer J · 2017 · English · PubMed Central

    Suppressor of cytokine signaling 1 (SOCS1) protein, which encodes a member of signal transducers and activators of transcription-induced inhibitors, takes part in a negative regulation of cytokine signaling. The mechanism of SOCS1 in tumor carcinogenesis is complex and there have been no studies…

  6. Journal Article Full text

    TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolution

    Hou, H-A; Chou, W-C; Kuo, Y-Y et al.

    Blood Cancer J · 2015 · English · PubMed Central

    The TP53 mutation is frequently detected in acute myeloid leukemia (AML) patients with complex karyotype (CK), but the stability of this mutation during the clinical course remains unclear. In this study, TP53 mutations were identified in 7% of 500 patients with de novo AML and 58.8% of patients…